ANUHPHR.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 06, 2026

Report Source: 2026 3rd Quarter Report

Anuh Pharma Ltd

Anuh Pharma Ltd. Stock Analysis ANUHPHR.NS

India Health Care Micro Cap Report:
Anuh Pharma Ltd. engages in the provision of manufacture of pharmaceuticals, medicinal chemical, and botanical products. The firm's products include active pharmaceutical ingredients and corticosteroids. Its active pharmaceutical ingredients include macrolides, anti-TB, anti-malarial, antibacterial, anti-hypertension, expectorant, quinolones, intermediates and under development. Its macrolides products include erythromycin, erythromycin ethyl succinate, erythromycin stearate, erythromycin estolate, erythromycin propionate, erythromycin phosphate, and others. Its anti-malarial products include sulfadoxine, pyrimethamine, and others. The firm's anti-hypertension products include losartan potassium, telmisartan and atorvastatin calcium. The firm's corticosteroids include anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, antihistamines and under development. Its anti-inflammatory products include dexamethasone Na phosphate, mometasone furoate and clobetasol butyrate.
Read More

Anuh Pharma Ltd (ANUHPHR.NS) Chart

Key Statistics of Anuh Pharma Ltd (ANUHPHR.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹78.00₹81.00

Today's Open

₹81.00

Volume

20.87K

P/E Ratio (TTM)

16.75

52 Week Range

₹67.00₹114.90

Market Cap

7.99B

Avg. Volume

51.83K

Dividend Yield

1.89%

Financial Metrics & Statements of Anuh Pharma Ltd (ANUHPHR.NS)

FAQ's for Anuh Pharma Ltd (ANUHPHR.NS)

  • According to Musaffa’s Shariah screening methodology, Anuh Pharma Ltd (ANUHPHR.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.